SUMMA RX LABORATORIES INC
10KSB40, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10KSB40, EX-23, 2000-09-26
Next: SUMMA RX LABORATORIES INC, 10KSB40, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10KSB
FOR THE YEAR ENDED APRIL 30, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FORM 10KSB FOR THE YEAR ENDED APRIL 30, 1998.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          APR-30-1998
<PERIOD-START>                             MAY-01-1997
<PERIOD-END>                               APR-30-1998
<CASH>                                         415,227
<SECURITIES>                                         0
<RECEIVABLES>                                  231,601
<ALLOWANCES>                                    73,161
<INVENTORY>                                    132,632
<CURRENT-ASSETS>                               790,764
<PP&E>                                       1,521,264
<DEPRECIATION>                                 487,339
<TOTAL-ASSETS>                               1,829,265
<CURRENT-LIABILITIES>                          547,500
<BONDS>                                        570,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                     680,307
<TOTAL-LIABILITY-AND-EQUITY>                 1,829,265
<SALES>                                      3,314,877
<TOTAL-REVENUES>                             3,319,157
<CGS>                                        1,703,723
<TOTAL-COSTS>                                3,009,700
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              38,526
<INCOME-PRETAX>                                270,931
<INCOME-TAX>                                  (68,000)
<INCOME-CONTINUING>                            338,931
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   338,931
<EPS-BASIC>                                        .10
<EPS-DILUTED>                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission